Literature DB >> 16337267

Uronic acids functionalized polyethyleneimine (PEI)-polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriers.

Sabine I Weiss1, Nathalie Sieverling, Maren Niclasen, Christof Maucksch, Andreas F Thünemann, Helmuth Möhwald, Dietrich Reinhardt, Joseph Rosenecker, Carsten Rudolph.   

Abstract

In this study, we investigated galacturonic (GalAc)- and mannuronic (ManAc) acids as novel targeting ligands for receptor-mediated gene delivery. GalAc and ManAc were coupled to either polyethyleneimine (PEI) or PEI-polyethyleneglycol (PEG). Furthermore, lactobionic acid (LacAc), which comprises a GalAc-related carbohydrate ring, was coupled to each of the polymers through its open-chain gluconic acid moiety. The molar mass distributions of the polymers were characterized by analytical ultracentrifugation and size exclusion chromatography. PEI-conjugate-pDNA complexes were transfected into HepG2-, HeLa-, and 16HBE14o(-)-cells. Gene expression mediated by GalAc- and LacAc-functionalized PEI-conjugates was lower than for PEI. In contrast, gene expression mediated by ManAc-functionalized PEI-conjugates was up to three orders of magnitude higher than for the other tested PEI-conjugates, in particular for negatively charged gene vectors at low N/P ratios, independent of the cell line. Pre-incubation of cells with an excess of ManAc before transfection significantly inhibited transfection rates only for ManAc-functionalized PEI-conjugates. Coupling of methyl-alpha-d-mannuronic acid to PEI resulted in significantly lower transfection rates than for ManAc-PEI based complexes. Together with fluorescence microscopy images of fluorescein-labelled ManAc-functionalized dextrans and FACS analyses of cells, these results demonstrate that receptor-mediated endocytosis of ManAc-PEI-conjugate-pDNA complexes via ManAc-specific receptors was involved in gene transfer. In conclusion, ManAc-modification of PEI-polymers represents a novel strategy for receptor-mediated gene delivery which could be promising for in vivo application.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337267     DOI: 10.1016/j.biomaterials.2005.11.011

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid.

Authors:  Clark J Needham; Austin K Williams; Sue Anne Chew; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomacromolecules       Date:  2012-04-11       Impact factor: 6.988

Review 2.  Carbohydrate polymers for nonviral nucleic acid delivery.

Authors:  Antons Sizovs; Patrick M McLendon; Sathya Srinivasachari; Theresa M Reineke
Journal:  Top Curr Chem       Date:  2010

3.  Plasmid-encapsulated polyethylene glycol-grafted polyethylenimine nanoparticles for gene delivery into rat mesenchymal stem cells.

Authors:  Xiao-Ai Chen; Li-Jun Zhang; Zhi-Jie He; Wei-Wei Wang; Bo Xu; Qian Zhong; Xin-Tao Shuai; Li-Qun Yang; Yu-Bin Deng
Journal:  Int J Nanomedicine       Date:  2011-04-21

4.  Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus.

Authors:  Qin Zeng; Jianfeng Han; Dong Zhao; Tao Gong; Zhirong Zhang; Xun Sun
Journal:  Int J Nanomedicine       Date:  2012-02-27

5.  Degradable copolymer based on amphiphilic N-octyl-N-quatenary chitosan and low-molecular weight polyethylenimine for gene delivery.

Authors:  Chengchu Liu; Qing Zhu; Wenhui Wu; Xiaolin Xu; Xiaoyu Wang; Shen Gao; Kehai Liu
Journal:  Int J Nanomedicine       Date:  2012-10-08

6.  Coupling of a bifunctional peptide R13 to OTMCS-PEI copolymer as a gene vector increases transfection efficiency and tumor targeting.

Authors:  Hui Lv; Qing Zhu; Kewu Liu; Manman Zhu; Wenfang Zhao; Yuan Mao; Kehai Liu
Journal:  Int J Nanomedicine       Date:  2014-03-11

Review 7.  Extracellular barriers in respiratory gene therapy.

Authors:  Niek Sanders; Carsten Rudolph; Kevin Braeckmans; Stefaan C De Smedt; Joseph Demeester
Journal:  Adv Drug Deliv Rev       Date:  2008-12-24       Impact factor: 15.470

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.